SAIC

Filed under: , , , , , , , , ,

Analyst Upgrades

  • Akamai (AKAM) to overweight from neutral at Piper Jaffray.
  • Las Vegas Sands (LVS) to buy from neutral at UBS.
  • Aetna (AET) to Outperform from market perform at Leerink.
  • Hot Topic (HOTT) to buy from neutral at Janney Capital.
  • Colonial Properties (CLP) upgraded to Outperform from market perform at FBR Capital and to buy from hold at Citigroup.
  • Altera (ALTR) to buy from hold at Citigroup.
  • American Reprographics (ARC), CarMax (KMX) and American Campus (ACC) to outperform from neutral at RW Baird.
  • Zebra Tech (ZBRA) to neutral from underweight at JPMorgan.
  • IMAX (IMAX) to buy from hold at Canaccord.
  • Basic Energy (BAS) to neutral from sell at Goldman.
  • Mednax (MD) to buy from neutral at BofA/Merrill.
  • UTi Worldwide (UTIW) to buy from hold at Stifel Nicolaus.

Continue reading Analyst Calls: AET, AKAM, BBY, DVN, HOG, IMAX, LVS, RIMM, UNH, URBN …

Analyst Calls: AET, AKAM, BBY, DVN, HOG, IMAX, LVS, RIMM, UNH, URBN … originally appeared on BloggingStocks on Fri, 25 Mar 2011 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Filed under: ,

“Today, one of the fastest growing fronts in defense is in cyberspace. And while cyber war this doesn’t involve tanks and fighter squadrons, its ability to disrupt an enemy can be just as effective,” says Steve Christ.

The editor of The Wealth Advisory explains, “That leads us to our newest recommendation — a diversified technical services company calledSAIC, Inc. (SAI).

“A report released in December by Input predicts that federal investment in cybersecurity will reach $13.3 billion by 2015, up from $8.6 billion in 2010. That’s a compound annual growth rate of 9.1%, nearly twice the rate of other government IT spending.

Continue reading SAIC. Inc. (SAI): Invest in Cyber-Security

SAIC. Inc. (SAI): Invest in Cyber-Security originally appeared on BloggingStocks on Tue, 01 Feb 2011 14:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Filed under: , ,

earnings expectationsInvestors nervous about the possibly stalled economic recovery — or worse, the beginning of the latter phase of a double-dip recession — were not pleased with last week’s housing numbers. Things were perhaps ameliorated somewhat by durable goods order numbers and a revised GDP that weren’t as bad as expected, but that didn’t stop the Dow from dipping below 10,000 later in the week, before fighting its way back above the benchmark to end the week, thanks largely to Fed chair Bernanke’s comments on Friday.

Though the end of August is usually quiet, this week lots more economic data are due out, including more housing numbers: The Case-Shiller Home Price Index for June on Tuesday, construction spending numbers for July on Wednesday, and NAR‘s pending home sales for July on Thursday. There’s not expected to be much to get excited about in these numbers.

Continue reading The Week in Preview: Employment, Housing, Manufacturing, Earnings Expectations

The Week in Preview: Employment, Housing, Manufacturing, Earnings Expectations originally appeared on BloggingStocks on Sun, 29 Aug 2010 12:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




BloggingStocksEconomyGross domestic productDurable goodRecession shapes

Filed under: , , , , , ,

Analyst Upgrades

  • Barclays upgraded GlaxoSmithKline (GSK) to overweight from equal weight and said investor concerns regarding Advair and Avandia are overdone.
  • Leerink upgraded Bristol-Myers (BMY) to outperform from market perform, citing management’s pipeline execution. Shares were also upgraded at Citigroup this morning to buy from hold.
  • Goldman upgraded Medco Health (MHS) to buy from neutral and raised its price target on shares to $76 from $67. The firm cites valuation and expectations that earnings will accelerate in 2H10 driven by a stronger generic outlook.
  • U.S. Steel (X) was upgraded to neutral from sell at UBS.
  • Blyth (BTH) was upgraded to hold from underperform at Jefferies.
  • IPC The Hospitalist Co. (IPCM) was upgraded to buy from hold at Deutsche Bank.

Continue reading Analyst Calls: BMY, FSLR, GSK, LGF, MHS, PVH, SAI, SU, WAG, X …

Analyst Calls: BMY, FSLR, GSK, LGF, MHS, PVH, SAI, SU, WAG, X … originally appeared on BloggingStocks on Fri, 11 Jun 2010 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




Bristol-Myers SquibbCitigroupDeutsche BankU.S. SteelBloggingStocks